TSS
ANIX icon

Two Sigma Securities’s Anixa Biosciences ANIX Stock Holding History

Two Sigma Securities’s Portfolio ANIX Stock Details ANIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-12,047
Closed -$28K – 2651
2017
Q4 		$28K Sell
12,047
-45,116
-79% -$117K ﹤0.01% 1595
2017
Q3 		$150K Buy
+57,163
New +$62.9K 0.01% 637

Other funds holding ANIX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
DIA
Denver Investment Advisors Denver, Colorado $1.89B AUM 7.9% 1-Year Est. Return
CAM
Concorde Asset Management Ann Arbor, Michigan $204M AUM
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Two Sigma Securities's ANIX Position: Q1 2018 in Review

Two Sigma Securities sold out of Anixa Biosciences (ANIX) in Q1 2018, closing a stake of 12,047 shares — an estimated $28K sold.

Two Sigma Securities first reported a position in ANIX in Q3 2017 and held it in 2 quarters. The position peaked at $150K in Q3 2017. 18 funds tracked by Wall St. Rank hold ANIX as of Q1 2018.

  • Two Sigma Securities reported no remaining Anixa Biosciences position as of Q1 2018 after selling out during the quarter.
  • Two Sigma Securities sold 12,047 Anixa Biosciences shares in Q1 2018, an estimated $28K.
  • Two Sigma Securities first reported a position in Anixa Biosciences in Q3 2017 and held it in 2 quarters.
  • Two Sigma Securities's Anixa Biosciences position peaked at $150K in Q3 2017.
  • 18 funds tracked by Wall St. Rank held Anixa Biosciences as of Q1 2018.

Based on Two Sigma Securities's 13F filing for Q1 2018, filed 15 May 2018.